IGF-1–Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1α/CXCR4 Signaling to Promote Myocardial Repair
Top Cited Papers
- 21 November 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 103 (11) , 1300-1308
- https://doi.org/10.1161/circresaha.108.186742
Abstract
We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth factor (IGF)-1 showed improved survival and engraftment in the infarcted heart and promoted stem cell recruitment through paracrine release of stromal cell–derived factor (SDF)-1α. Rat bone marrow–derived MSCs were used as nontransduced (NormMSCs) or transduced with adenoviral-null vector (NullMSCs) or vector encoding for IGF-1 (IGF-1MSCs). IGF-1MSCs secreted higher IGF-1 until 12 days of observation (PNullMSCs). Molecular studies revealed activation of phosphoinositide 3-kinase, Akt, and Bcl.xL and inhibition of glycogen synthase kinase 3β besides release of SDF-1α in parallel with IGF-1 expression in IGF-1MSCs. For in vivo studies, 70 μL of DMEM without cells (group 1) or containing 1.5×106NullMSCs (group 2) or IGF-1MSCs (group 3) were implanted intramyocardially in a female rat model of permanent coronary artery occlusion. One week later, immunoblot on rat heart tissue (n=4 per group) showed elevated myocardial IGF-1 and phospho-Akt in group 3 and higher survival of IGF-1MSCs (PNullMSCs) (n=6 per group). SDF-1α was increased in group 3 animal hearts (20-fold versus group 2), with massive mobilization and homing of ckit+, MDR1+, CD31+, and CD34+ cells into the infarcted heart. Infarction size was significantly reduced in cell transplanted groups compared with the control. Confocal imaging after immunostaining for myosin heavy chain, actinin, connexin-43, and von Willebrand factor VIII showed extensive angiomyogenesis in the infarcted heart. Indices of left ventricular function, including ejection fraction and fractional shortening, were improved in group 3 as compared with group 1 (P<0.05). In conclusion, the strategy of IGF-1 transgene expression induced massive stem cell mobilization via SDF-1α signaling and culminated in extensive angiomyogenesis in the infarcted heart.Keywords
This publication has 36 references indexed in Scilit:
- Formation of large coronary arteries by cardiac progenitor cellsProceedings of the National Academy of Sciences, 2008
- Stromal Cell–Derived Factor-1α Confers Protection Against Myocardial Ischemia/Reperfusion InjuryCirculation, 2007
- Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2007
- Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and FunctionMolecular and Cellular Biology, 2007
- Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditisJournal of Molecular and Cellular Cardiology, 2007
- Short‐term treatment using insulin‐like growth factor‐1 (IGF‐1) improves life expectancy of the delta‐sarcoglycan deficient hamsterThe Journal of Gene Medicine, 2006
- Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarctionProceedings of the National Academy of Sciences, 2006
- Strategic advantages of insulin‐like growth factor‐I expression for cardioprotectionThe Journal of Gene Medicine, 2002
- Insulin-like Growth Factor-1 Receptor and Its Ligand Regulate the Reentry of Adult Ventricular Myocytes into the Cell CycleExperimental Cell Research, 1997
- Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase PathwaysJournal of Biological Chemistry, 1997